Plain-English translation of NCT07250347 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing an artificial intelligence (AI) system designed to help doctors better detect stomach cancer and determine its stage using CT scans. The study involves analyzing CT images from patients with confirmed stomach cancer who are scheduled for surgery, and comparing how well the AI performs against expert radiologists reading the images on their own.
Current methods for detecting and staging stomach cancer rely on radiologists' interpretations, which can vary between doctors and locations. This trial aims to see whether AI assistance can improve accuracy, speed up diagnosis, and work reliably across different hospitals and imaging equipment.
You likely qualify if…
You likely don't qualify if…
Most participants in this study will not have additional visits or tests beyond their standard cancer care. Researchers will use your existing CT scan images and surgical records that were already obtained as part of your treatment planning. The AI system will analyze these images, and doctors will compare the AI's results with expert radiologists' interpretations and your final surgical findings to see how accurate the tool is.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Jiangsu Cancer Institute & Hospital, Zhengzhou University
Enrollment target
~8,000 participants
Started
August 2025
Primary completion
December 2028
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhang Yudong, PHD, MD
The First Affiliated Hospital with Nanjing Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.